BioClonal is thrilled to participate in PEGS Europe 2024, a premier event dedicated to the latest advancements in protein and antibody engineering. This conference provides an excellent platform for industry leaders, researchers, and innovators to come together, share insights, and explore collaboration opportunities.
We invite you to join us for engaging discussions about our pioneering technologies and how we are revolutionizing the development of monoclonal antibodies. At PEGS Europe, you’ll have the chance to learn more about our unique approach to addressing challenging targets in the biopharmaceutical landscape.
We look forward to connecting with you at PEGS Europe 2024! Whether you’d like to schedule a meeting or engage in meaningful conversations, we can’t wait to discuss potential collaborations and explore how we can work together to drive scientific progress.